Abbott's Panbio Rapid Antigen Test gains CE Mark for use on children
First rapid antigen test with performance data on children
First rapid antigen test with performance data on children
Sensor could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse
Anti-cancer drug delivery to target tumor sites now becomes more effective with novel multi-stimuli-responsive drug delivery systems
An insider’s view on leveraging the latest single-cell technologies, including cell sorting and single-cell sequencing, to understand what drives response or resistance in checkpoint therapies
The company will receive up to $5 million in grant funds from DARPA as part of the agency’s Nucleic Acids On-Demand World-Wide Program to plan for and prevent the next viral pandemic
The MDC Lighthouse Lab in Cheshire, which plays a key role in the UK Government’s COVID-19 testing rollout, has announced it has processed its 10 millionth test
Dr. Tania Nolan outlines how her team is designing assays to identify new variants and why these are critical to managing the global response
The test offers 98.0% clinical sensitivity for samples with PCR Ct values up to 31
The Ultreon 1.0 Software helps physicians automatically detect and quantify blood vessel characteristics, giving them better insights for optimal patient treatment
Each line of ValuPanel Reagents consists of separately delivered probes and primers, which allow assay flexibility and sizes that can help facilitate scale-up
AI could hold the key to more targeted treatment, according to new research
VENTANA MMR RxDx Panel is the first immunohistochemistry predictive test in endometrial cancer for treatment with the anti-PD1 immunotherapy JEMPERLI
Dr. David Andrews, AstraZeneca, discusses the future of small-molecule drug discovery for PPIs
Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more
The BinaxNOW Self-Test will be sold in 2-count packs for an MSRP of $23.99, making it an affordable over-the-counter COVID-19 rapid test available in the U.S.
Watch this on-demand webinar to learn about the mechanisms behind cancer treatments such as CAR-T cells, checkpoint inhibitors or adoptive T cell therapy